Skye Bioscience
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SKYE and other ETFs, options, and stocks.About SKYE
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion.
CEOPunit S. Dhillon
CEOPunit S. Dhillon
Employees16
Employees16
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2011
Founded2011
Employees16
Employees16
SKYE Key Statistics
Market cap24.69M
Market cap24.69M
Price-Earnings ratio-0.62
Price-Earnings ratio-0.62
Dividend yield—
Dividend yield—
Average volume602.24K
Average volume602.24K
High today$0.9602
High today$0.9602
Low today$0.7627
Low today$0.7627
Open price$0.781
Open price$0.781
Volume806.10K
Volume806.10K
52 Week high$5.75
52 Week high$5.75
52 Week low$0.76
52 Week low$0.76
Stock Snapshot
Skye Bioscience(SKYE) stock is priced at $0.80, giving the company a market capitalization of 24.69M. It carries a P/E multiple of -0.62.
On 2025-12-29, Skye Bioscience(SKYE) stock moved within a range of $0.76 to $0.96. With shares now at $0.80, the stock is trading +5.1% above its intraday low and -16.5% below the session's peak.
Trading volume for Skye Bioscience(SKYE) stock has reached 806.1K, versus its average volume of 602.24K.
Over the past 52 weeks, Skye Bioscience(SKYE) stock has traded between a high of $5.75 and a low of $0.76.
Over the past 52 weeks, Skye Bioscience(SKYE) stock has traded between a high of $5.75 and a low of $0.76.
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
25%
Sell
0%
People also own
Based on the portfolios of people who own SKYE. This list is generated using Robinhood data, and it’s not a recommendation.